Stockscreener 앱 받기
6.59
1.08%
-0.19
전일 마감가:
$6.78
열려 있는:
$6.64
하루 거래량:
280.91K
Relative Volume:
1.03
시가총액:
$252.57M
수익:
$239.40M
순이익/손실:
$104.44M
주가수익비율:
2.2264
EPS:
2.96
순현금흐름:
$-18.50M
1주 성능:
-8.75%
1개월 성능:
+11.78%
6개월 성능:
-27.34%
1년 성능:
-62.26%
1일 변동 폭
$6.38
$6.81
1주일 범위
$6.35
$7.41
52주 변동 폭
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
명칭
Entrada Therapeutics Inc
전화
857-305-1825
주소
ONE DESIGN CENTER PLACE, BOSTON
TRDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
6.64 | 257.89M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.04 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.25 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.91 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | ROTH MKM | Buy |
| 2024-01-05 | 개시 | Oppenheimer | Outperform |
| 2023-04-03 | 개시 | H.C. Wainwright | Buy |
Entrada Therapeutics Inc 주식(TRDA)의 최신 뉴스
How risky is Entrada Therapeutics Inc. stock nowAnalyst Downgrade & Safe Capital Growth Plans - newser.com
Why Entrada Therapeutics Inc. stock is favored by pension fundsTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Can Entrada Therapeutics Inc. stock resist market sell offsJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
Visualizing Entrada Therapeutics Inc. stock with heatmapsEarnings Overview Report & Precise Trade Entry Recommendations - newser.com
Entrada Therapeutics, Inc. (TRDA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Entrada Therapeutics, Inc. (TRDA) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Will Entrada Therapeutics Inc. stock gain from strong economy2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Real time pattern detection on Entrada Therapeutics Inc. stockQuarterly Profit Review & Smart Allocation Stock Tips - newser.com
Does Entrada Therapeutics Inc. stock trade at a discount to peersChart Signals & Fast Exit and Entry Trade Guides - newser.com
Multi factor analysis applied to Entrada Therapeutics Inc.Market Performance Summary & Verified Chart Pattern Trade Signals - newser.com
How Entrada Therapeutics Inc. stock benefits from strong dollarChart Signals & Reliable Price Action Trade Plans - newser.com
Applying big data sentiment scoring on Entrada Therapeutics Inc.Buy Signal & Accurate Entry and Exit Point Alerts - newser.com
Understanding Entrada Therapeutics Inc.’s price movementPortfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
Entrada Therapeutics, Inc. (TRDA) stock forecast and price target - Yahoo! Finance UK
Applying sector rotation models to Entrada Therapeutics Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Entrada Therapeutics Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Is Entrada Therapeutics Inc. forming a bottoming baseJuly 2025 Intraday Action & Accurate Trade Setup Notifications - newser.com
Entrada Therapeutics: Undervalued Leader in RNA Therapeutics with Promising DMD Pipeline - TipRanks
Using Python tools to backtest Entrada Therapeutics Inc. strategies2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
Entrada Therapeutics (TRDA) Expected to Announce Earnings on Tuesday - MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Analyzing Entrada Therapeutics Inc. with multi timeframe chartsEarnings Risk Report & Reliable Volume Spike Alerts - newser.com
Entrada Therapeutics to Present at Upcoming Investor Conferences - The Manila Times
Entrada (Nasdaq: TRDA) to present at Jefferies London and Evercore Miami conferences - Stock Titan
Entrada Therapeutics (NASDAQ:TRDA) Stock Price Up 7% – What’s Next? - Defense World
Will Entrada Therapeutics Inc. stock maintain dividend yieldWeekly Trade Recap & Weekly High Return Stock Opportunities - fcp.pa.gov.br
Published on: 2025-10-27 16:51:27 - newser.com
Is Entrada Therapeutics Inc. stock a top momentum playJuly 2025 Movers & Technical Buy Zone Confirmations - fcp.pa.gov.br
Published on: 2025-10-27 06:13:39 - newser.com
Entrada Therapeutics Inc (TRDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):